- Investigator
- Thomas J George
Clinical trials
-
Sorafenib Plus Capecitabine(SORCAPE) in Previously Treated Metastatic Colorectal Cancer -
BLUE-C The primary objective of this study is to assess the sensitivity for colorectal cancer (CRC) and specificity of the mt-sDNA 2.0 test.
- Ages
- 40 Years - N/A
- Sexes
- All
-
Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy for Limited mCRC(ERASur) This phase III trial compares total ablative therapy and usual systemic therapy to usual systemic therapy alone in treating patients with colorectal cancer that has spread to up to 4 body sites (limited metastatic). The usual approach for patients鈥�
- Investigator
- Kathryn E Hitchcock
- Ages
- 18 Years - N/A
- Sexes
- All